GlassScriptPhysician profile
Ammar Safar
NPI 1558334581
$8,422.63
in general payments reported to CMS, 2019-2025
19 companies · $1,064 in 2025
The $1,064 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,767 · 2021: $371 · 2022: $3,623 · 2023: $690 · 2024: $907 · 2025: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,152 · Travel and Lodging: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,152.40 |
| Travel and Lodging | $509.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,958.36 | 2022 | |
| Medtronic Vascular, INC. | $1,288.71 | 2019 | |
| Angiodynamics, INC. | $852.27 | 2022-2025 | Alphavac, Angiovac |
| Abiomed | $670.89 | 2022-2025 | Impella |
| Boston Scientific Corporation | $628.55 | 2019-2025 | Ranger |
| Abbott Laboratories | $619.30 | 2021-2024 | Diamondback Coronary, Jeti All In One Non-Sterile Kit |
| Medtronic, INC. | $318.08 | 2023-2025 | Symplicity G3, Corevalve Evolut R, Tyrx |
| Veryan Medical Incorporated | $215.42 | 2021 | |
| Stryker Corporation | $154.81 | 2025 | Flowtriever |
| Terumo Medical Corporation | $136.96 | 2024 | Glidesheath Slender, Tr Band, Metacross Otw |
| Inari Medical, INC. | $126.32 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $124.52 | 2024 | Xarelto |
| Livanova USA, INC. | $73.24 | 2023 | Lifesparc |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.46 | 2023 | Jardiance |
| Shockwave Medical, INC | $67.01 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $66.58 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.36 | 2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 | |
| Pfizer INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammar Safar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.